(Q45103515)

9 December 2017

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis (English)

1 reference

9 December 2017

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

Wiesner RH

1

1 reference

9 December 2017

Grambsch PM

2

1 reference

9 December 2017

Dickson ER

3

1 reference

9 December 2017

Ludwig J

4

1 reference

9 December 2017

MacCarty RL

5

1 reference

9 December 2017

Hunter EB

6

1 reference

9 December 2017

Fleming TR

7

1 reference

9 December 2017

Fisher LD

8

1 reference

9 December 2017

Beaver SJ

9

1 reference

9 December 2017

LaRusso NF

10

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

430-436

1 reference

9 December 2017

4

1 reference

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

9 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Current concepts. Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Sclerosing cholangitis in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Is primary sclerosing cholangitis a bad disease?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Orthotopic liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Multivariate survival analysis using Cox's regression model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Primary sclerosing cholangitis: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Long-standing asymptomatic primary sclerosing cholangitis report of three cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Is primary sclerosing cholangitis a progressive disease or not?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Prognostic factors in cirrhosis identified by Cox's regression model.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100406

7 January 2021

Identifiers

DOI

10.1002/HEP.1840100406

1 reference

9 December 2017

1 reference